Probably no aspect of the new Medicare drug program has caused more confusion and irritation than the notorious “doughnut hole,” a gap in coverage that forces people who had been getting their drugs cheaply to suddenly pay the full price out of pocket. Now, an analysis has quantified what happened last year when millions of beneficiaries fell into the gap. For patients with serious chronic...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Medicare’s Troubling Drug Gap
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account